Keyphrases
Multidetector Computed Tomography
50%
Left Ventricular Function
50%
Prosthetic Valve Thrombosis
50%
Antiphospholipid Antibody Syndrome
50%
Cor Triatriatum Sinister
50%
Renal Arteriovenous Fistula
50%
Recurrent Admissions
50%
Acoustic Activation
50%
Functioning Assessment
25%
Left Atrial Size
20%
Ascending Aneurysm
16%
Dyspnea on Exertion
16%
Material Delivery
12%
Imaging Methods
12%
Radiation Contrast
12%
Cardiac Function Assessment
12%
Advanced Technologies
12%
Embolic Complications
12%
Thrombolytic Therapy
12%
Volumetric Analysis
12%
Submillimeter
12%
Acquiring Data
12%
Cardiac Pathology
12%
Long-term Anticoagulation
12%
Threshold Method
12%
Spatial Resolution
12%
Reconstruction Technique
12%
Electrocardiogram Gating
12%
Function Variable
12%
Three-dimensional (3D)
12%
Global Left
12%
Evaluation Management
12%
Technique Innovation
12%
Coronary CT Angiography
12%
Technological Innovation
12%
Regional Function
12%
Retrospective Follow-up
10%
Dobutamine Echocardiography
10%
Two-dimensional Measurement
10%
Left Atrial Dimension
10%
Noninvasive Risk Stratification
10%
History of Myocardial Infarction
10%
Great Cardiac Vein
8%
Gas Core
7%
Acute Myocardial infarction/ST-segment Elevation Myocardial Infarction
5%
Medicine and Dentistry
Mechanical Index
50%
Antiphospholipid Antibody
50%
Heart Muscle Perfusion
50%
Kidney Arteriovenous Fistula
50%
Heart Left Ventricle Function
50%
Multidetector Computed Tomography
50%
Cor Triatriatum
50%
Prosthetic Valve Thrombosis
50%
Transesophageal Echocardiogram
25%
Mitral Valve Disease
25%
Left Atrium
25%
Heart Death
16%
Computed Tomography Angiography
12%
Cardiac Pathology
12%
Heart Function
12%
Fluorocarbon
6%
Myocardial Infarction
6%
Echo Contrast Medium
6%
Infarction
6%
Infusion
6%
Perflutren
6%
Perfluorobutane
6%
Magnetic Resonance Imaging
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infarction
100%
Heart Infarction
100%
Perflubutane
50%
Tissue Plasminogen Activator
50%
Perflutren
50%
Fluorocarbon
50%
Echo Contrast Medium
50%
Acute Heart Infarction
16%
Fibrinolytic Therapy
16%
ST Segment Elevation Myocardial Infarction
16%
Thrombosis
16%
Clinical Trial
16%
